A New Daily Cholesterol Pill Could Make Treatment Easier for Millions
For many people living with high cholesterol, the journey is familiar. It often begins with healthier eating, regular exercise, and eventually a statin medication. While these treatments help many people, some still struggle to bring their LDL (“bad”) cholesterol down to recommended levels.
For years, one of the most effective next steps has been PCSK9 inhibitor injections. These medicines can dramatically lower LDL cholesterol, but regular injections aren’t ideal for everyone.
Now, a new once-daily pill called enlicitide is attracting attention because it aims to deliver similar cholesterol-lowering benefits in an oral form.
Why LDL Cholesterol Matters
LDL cholesterol is often called “bad” cholesterol because excess amounts can build up inside blood vessels over time. This buildup, known as plaque, can increase the risk of heart attacks and strokes.
Lowering LDL cholesterol is one of the most effective ways to reduce cardiovascular risk, especially for people who already have heart disease or inherited forms of high cholesterol.
How Enlicitide Works
Our liver naturally removes LDL cholesterol from the bloodstream using LDL receptors.
A protein called PCSK9 reduces the number of these receptors by breaking them down. When fewer receptors are available, more LDL cholesterol remains in the blood.
Enlicitide is designed to block the PCSK9 protein. By preventing PCSK9 from destroying LDL receptors, the liver can continue clearing LDL cholesterol more efficiently.
Unlike existing PCSK9 medicines that are given by injection, enlicitide is taken as a tablet once a day.
What Clinical Studies Found
Large Phase III clinical trials involving nearly 3,000 participants evaluated enlicitide in people who were already taking statin therapy but still had elevated LDL cholesterol.
Researchers reported that:
- Daily enlicitide produced substantial reductions in LDL cholesterol compared with placebo.
- Many participants reached recommended LDL targets for people at high cardiovascular risk.
- The medication was studied alongside standard statin treatment rather than as a replacement.
- The overall safety profile observed during the trials was similar to placebo, although long-term monitoring will continue after approval.
These findings have generated interest because they suggest an oral option may become available for patients who previously needed injectable PCSK9 therapies.
Who Might Benefit?
Enlicitide is not intended for everyone with high cholesterol.
Doctors may consider it for people who:
- Have established cardiovascular disease.
- Have familial hypercholesterolemia (an inherited condition causing very high cholesterol).
- Cannot reach LDL goals despite taking statins.
- Need additional cholesterol lowering based on their individual risk.
Treatment decisions always depend on a person’s medical history, cholesterol levels, and overall cardiovascular risk.
Does This Replace Statins?
For most people, the answer is no.
Statins remain the recommended first-line treatment because they are well studied, effective, and widely available.
If LDL cholesterol remains above target despite statin therapy, healthcare providers may recommend adding another medication rather than replacing the statin.
Enlicitide could become one of those additional treatment options for appropriate patients.
What This Could Mean for Patients
Some people prefer taking a daily tablet instead of scheduling regular injections. If an oral medicine can provide similar cholesterol-lowering effects, it may improve convenience and make long-term treatment easier for some patients.
However, medication is only one part of heart health. Healthy eating, regular physical activity, maintaining a healthy weight, avoiding tobacco, and managing blood pressure and diabetes continue to play essential roles in reducing cardiovascular risk.
Enlicitide represents an important development in cholesterol management by offering a new oral approach to targeting the PCSK9 pathway. Early clinical trial results are encouraging, particularly for people who need additional LDL cholesterol lowering beyond statins.
As with any new medication, it’s important to discuss the potential benefits, risks, and suitability with your healthcare provider. The best treatment plan is one that considers your individual health needs and long-term cardiovascular goals.
Photo by Michele Blackwell on Unsplash
About Wellcore Weekly: Wellcore Weekly covers health, wellness, nutrition, sleep, fitness, and medical research with timely, easy-to-understand updates for everyday readers.
